-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Km8jofnxBbaJiPxolYV6rZrPTSO2+i+0FmlXNdbzYprZjonX4dDtqwDI3INb+nBP A2io82KWM0uZ5oukI7YwOg== 0001104659-06-075801.txt : 20061116 0001104659-06-075801.hdr.sgml : 20061116 20061116153743 ACCESSION NUMBER: 0001104659-06-075801 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20061115 ITEM INFORMATION: Unregistered Sales of Equity Securities FILED AS OF DATE: 20061116 DATE AS OF CHANGE: 20061116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: METABOLIX, INC. CENTRAL INDEX KEY: 0001121702 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS PLASTIC PRODUCTS [3080] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33133 FILM NUMBER: 061222990 BUSINESS ADDRESS: STREET 1: 21 ERIE ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-492-0505 MAIL ADDRESS: STREET 1: 21 ERIE ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: METABOLIX INC DATE OF NAME CHANGE: 20000810 8-K 1 a06-24123_18k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported)  November 15, 2006

METABOLIX, INC.

(Exact Name of Registrant as Specified in Its Charter)

DELAWARE

(State or Other Jurisdiction of Incorporation)

0-33133

 

04-2729386

(Commission File Number)

 

(IRS Employer Identification No.)

 

21 Erie Street, Cambridge, Massachusetts

 

02139

(Address of Principal Executive Offices)

 

(Zip Code)

 

(617) 492-0505

(Registrant’s Telephone Number, Including Area Code)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



 

INFORMATION TO BE INCLUDED IN THE REPORT

Item 3.02            Unregistered Sales of Equity Securities.

On November 15, 2006, Metabolix, Inc. (the “Company”) sold 535,714 shares of Common Stock to Archer Daniels Midland Company (“ADM”), an existing stockholder and the Company’s collaborative partner, at $14.00 per share for aggregate consideration of $7,499,996.  The purchase was made pursuant to a Stock Purchase Agreement dated July 12, 2006 by and between the Company and ADM.  There were no underwriters participating in this transaction. In connection with the offer and sale of securities to ADM, the Company relied on the exemption from registration provided by Section 4(2) of the Securities Act of 1933, as amended, because there was only one offeree, ADM, which is an accredited investor, an existing stockholder and the Company’s collaborative partner.

2



 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

METABOLIX, INC.

 

 

 

 

 

 

 

 

Date

November 16, 2006

 

By:

/s/ Thomas G. Auchincloss, Jr.

 

 

 

Thomas G. Auchincloss, Jr.

 

 

 

Chief Financial Officer

 

3


 -----END PRIVACY-ENHANCED MESSAGE-----